Opioid Use Disorder

Core concept

A problematic pattern of opioid use leading to clinically significant impairment or distress, reflected in a cluster of behavioral, physiological, and craving-related symptoms occurring within a 12-month period.

Plain-language explanation

Opioid Use Disorder is diagnosed along a severity spectrum based on how many of eleven symptom domains are present -- impaired control over use, social impairment, risky use, and pharmacological features (tolerance, withdrawal) -- rather than as a single yes/no state. It includes both prescription opioid misuse and illicit opioid use; severity (mild/moderate/severe) is based on symptom count, not the specific substance or route of use.

Developmental considerations

Can develop at any age; a common and clinically important pathway is initiation through an appropriate medical prescription (as in this pilot's case example) rather than non-medical use, which carries different stigma and screening implications and should be assessed with particular attention to avoid dismissing legitimate pain treatment needs.

Functional impact

Can affect work, relationships, and physical safety; overdose risk is a distinct, serious safety consideration, particularly after a period of reduced tolerance.

Associated features

Tolerance and withdrawal criteria are treated with clinical nuance when opioids are used exactly as prescribed under appropriate medical supervision -- those two physiological criteria alone, in that context, don't count toward the diagnosis, since they reflect expected pharmacology rather than a problematic pattern.

Cultural considerations

Stigma, access to treatment, and the social/legal consequences of opioid use vary substantially by context, shaping both help-seeking and how readily the disorder is recognized versus criminalized.

Common misconception

A common misconception is that anyone taking prescribed opioids for pain, including those who develop physical tolerance or withdrawal, 'has' a use disorder. Physiological dependence under appropriate medical supervision is expected pharmacology, not itself a disorder -- the diagnosis requires the behavioral and psychological symptom cluster, not tolerance/withdrawal alone.

Reconsider this formulation

If the only features present are tolerance and withdrawal in the context of appropriately supervised medical use, with no loss of control, craving, or functional impairment, reconsider that no disorder is present.

Example fictional case

A 29-year-old, after a wisdom-tooth extraction six months ago, describes taking more of their leftover prescription than intended most days, has unsuccessfully tried to stop twice, thinks about the medication throughout the day, and has missed several work shifts as a result.

References

APA (2022). DSM-5-TR, Substance-Related and Addictive Disorders chapter.

Recognition pattern

At least two of eleven symptom criteria within 12 months -- e.g., using more or longer than intended, unsuccessful efforts to cut down, craving, use despite social/interpersonal problems, tolerance, and withdrawal -- with severity scaling by symptom count (2-3 mild, 4-5 moderate, 6+ severe).

What to notice

• Using more opioid, or for longer, than intended
• Persistent desire or unsuccessful efforts to cut down or control use
• Strong craving or urge to use
• Continued use despite it causing or worsening social or relationship problems
• Tolerance or withdrawal symptoms when not using
• Important activities given up or reduced because of use

Distinguish

Distinguish appropriately supervised medical opioid use (tolerance/withdrawal alone, no behavioral symptoms) from Opioid Use Disorder (behavioral/psychological symptom cluster present).

Differential considerations

Appropriate medical use of prescribed opioids under supervision, without the behavioral/psychological symptoms (craving, loss of control, use despite harm), does not itself constitute a disorder -- tolerance and withdrawal from properly supervised use are excluded from counting toward diagnosis for that reason. Other Substance Use Disorders can co-occur or look superficially similar in behavioral pattern, but are distinguished by which substance is involved and its specific withdrawal syndrome.

Commonly confused conditions

• Alcohol Use Disorder

Related comparisons

Reasoning prompts

• Why do tolerance and withdrawal alone, in a supervised medical context, not meet criteria on their own?
• What is the clinical significance of the overdose-risk note after a period of abstinence?

Clarifying questions to ask

• Does the pattern of loss-of-control behavior involve an ingested substance (pointing to Opioid Use Disorder) or a behavior like gambling with no substance involved (pointing to Gambling Disorder)?
• Is there physiological tolerance and withdrawal present, which is a defined feature of Opioid Use Disorder but not a physiological feature of Gambling Disorder?
• Is the patient currently in withdrawal, and if so, are there signs (seizure, confusion, autonomic instability) suggesting a medically dangerous alcohol withdrawal rather than an uncomfortable but non-lethal opioid withdrawal?
• Has the pattern of use caused impairment across the required behavioral domains, independent of the substance's legal status?
• Is the patient using opioids and sedative-hypnotics together, which would substantially raise overdose risk beyond either substance alone?
• If withdrawal is occurring, are seizure-risk features present, which would point more toward sedative-hypnotic-anxiolytic withdrawal management priorities?
• Is the patient's presentation more consistent with sedation and constricted pupils (opioid) or activation and dilated pupils (stimulant)?
• Is there evidence of combined opioid-and-stimulant use, which would raise the risk that one substance's effects are masking the other's danger signs?

Case Lab

Practice questions

2 question(s) reference this disorder. Practice Opioid Use Disorder →